Form 8-K - Current report:
SEC Accession No. 0001628280-19-008232
Filing Date
2019-06-21
Accepted
2019-06-21 16:05:41
Documents
5
Period of Report
2019-06-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K june2019biohaven8-k.htm 8-K 25450
2 EXHIBIT 1.1 exhibit11-2019junebiohaven.htm EX-1.1 225938
3 EXHIBIT 5.1 exhibit51-2019junebiohaven.htm EX-5.1 26878
4 maplesgrouplogo.jpg GRAPHIC 64057
5 maplesgrouplogofooter.jpg GRAPHIC 80046
  Complete submission text file 0001628280-19-008232.txt   478010
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38080 | Film No.: 19911561
SIC: 2834 Pharmaceutical Preparations